CNS Response Ranked Top 25 in Intellectual Property
GlobeNewswire - Fri Jun 26, 8:30AM CDT
CNS Response, Inc. (OTCQB:CNSO) CNS Response is ranked as one of 25 leading patent holders in pervasive neurotechnology, according to a recently released report on over 800 organizations by researcher SharpBrains. CNS Response is ranked 21, based on the strength of its intellectual property, in the report titled "Pervasive Neurotechnology: A Groundbreaking Analysis of 10,000+ Patent Filings Transforming Medicine, Health, Entertainment, and Business." Other firms ranked according to the IP Strength Index include the Nielsen Company (#1 overall), Medtronic (#3), Microsoft (#4), Neuronetics (#
MDT: 74.37 (+1.28), IBM: 166.95 (+3.10)
CNS Response Applauds Passage of Clay Hunt Suicide Prevention Act - an Important Step Forward for Independent Oversight and Evidence-Based Medicine
GlobeNewswire - Tue Feb 03, 11:18AM CST
CNS Response, Inc. (OTCQB:CNSO) applauds the 114th Congress for passing the Clay Hunt Suicide Prevention for American Veterans Act today. On average one active service member and 22 veterans are said to be taking their own lives each day. The independent oversight and evidence-based medicine called for in this bill could not come soon enough--especially for the families and loved ones of those veterans who did not receive the help they needed or deserved.
CNS Response to be Featured on "The Doctors"
GlobeNewswire - Tue Jan 27, 1:39PM CST
CNS Response, Inc. (OTCQB:CNSO)
CNS Response CEO Interviewed on CNBC World's Squawk Box
GlobeNewswire - Tue Jan 20, 6:08AM CST
CNS Response, Inc. (OTCQB:CNSO)
Dave Gentry Features Top 5 Healthcare Stocks for 2015 on This Week's RedChip Money Report on Fox Business and Bloomberg
GlobeNewswire - Tue Dec 16, 2:52PM CST
RedChip Companies, Inc. ("RedChip"
OPXA: 0.44 (-0.01), ATNM: 2.41 (+0.18), AKER: 4.49 (+0.39), CGIX: 11.55 (+0.30)
CNS Response to Host Webinar to Discuss Key Revenue Drivers for Its Unique Mental Health Technology
GlobeNewswire - Wed Dec 10, 6:00AM CST
CNS Response, Inc. (OTCQB:CNSO)
Avoiding the Wrong Medication is the Best Place to Start: CNS Response Congressional Testimony on Suicide Prevention
GlobeNewswire - Thu Nov 20, 9:12AM CST
CNS Response, Inc. (OTCBB:CNSO)
Congressional Testimony From CNS Response to Feature Key Findings in Suicide Prevention
GlobeNewswire - Fri Nov 07, 8:35AM CST
CNS Response, Inc. (OTCBB:CNSO)
Accelerating the Adoption Curve: Improving Patient Outcomes in Psychiatry
GlobeNewswire - Fri Sep 12, 8:00AM CDT
CNS Response, Inc. (OTCBB:CNSO): George C. Carpenter, CEO of CNS Response will be speaking at the upcoming Frost and Sullivan Growth, Innovation and Leadership conference: "The Future of Value Based Care Delivery," as part of the expert panel on "Prospering in a Radically New Healthcare Landscape." The session takes place on Tuesday, September 16th from 1:50pm to 3:20pm at the Fairmont Hotel in San Jose, CA.
RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg
GlobeNewswire - Tue Sep 09, 1:34PM CDT
RedChip Companies, Inc. ("RedChip"
IQNT: 17.76 (+0.22), AKER: 4.49 (+0.39)